Poster Session 60RCC: MEDICAL TREAT MENTSunday, 20 March, 15.45-17.15, Hall H725 SEQUENTIAL USE OF MTOR -INHIBITORS IN PATIENTS WITH METASTATIC RENAL CELL CARCINOMA (MRCC): SAFETY AND EFFICACY FOLLOWING FAILURE OF RECEPTOR TYROSINE KINASE INHIBITOR (TKI) TREATMENT